反応式
[CH:1]([C:4]1[CH:9]=[CH:8][CH:7]=[C:6]([CH:10]([CH3:12])[CH3:11])[C:5]=1[N:13]=[C:14]=[S:15])([CH3:3])[CH3:2].Cl.C([O:19][C:20](=O)[CH2:21][NH:22][CH3:23])C.C(N(CC)CC)C>C(Cl)(Cl)Cl>[CH:1]([C:4]1[CH:9]=[CH:8][CH:7]=[C:6]([CH:10]([CH3:11])[CH3:12])[C:5]=1[N:13]1[C:20](=[O:19])[CH2:21][N:22]([CH3:23])[C:14]1=[S:15])([CH3:2])[CH3:3]参加物
5
実験手順
The title compound was prepared by the procedure described in Example 1 using 8.3 g of 2,6-diisopropylphenyl-isothiocyanate, 5.8 g of sarcosine ethyl ester hydrochloride, 14.5 g of triethyl amine, and 200 mL of chloroform. Crystallization from diethyl ether/hexane mixture afforded the title compound (6.6 g) as a tan solid, m.p. 174°-176° C. Anal. Calcd. for C16H22N2OS: C, 66.17; H, 7.63; N, 9.64. Found: C, 66.39; H, 7.63; N, 9.59. Mass spectrum (+FAB, [M+H]+) m/z 269/271.
後処理
- customThe title compound was prepared by the procedure
- customCrystallization from diethyl ether/hexane mixture
出典と根拠
- ORDレコード
- ord-41693961050241339f4fa0e3f228e058
- 出典データセット
- uspto-grants-1999_01
- 特許番号
- US05861517
関連ノート
読み込み中…